Advertisement

Laboratory Testing and Predictors of Severe Postpartum Hemorrhage

  • Evelyn Lockhart
Chapter

Abstract

Multidisciplinary management of obstetric hemorrhage requires rapid identification of its underlying etiology. As part of this management, laboratory assessment for coagulopathy is often performed. The following case study reviews the data on laboratory markers which predict progression to severe postpartum hemorrhage, juxtaposing the physiologic changes in obstetric hemostasis with interpreting abnormal values. Notably, fibrinogen has emerged from several studies as a marker for progression to severe postpartum hemorrhage. The case study also reviews recommendations for periodicity in laboratory testing during obstetric hemorrhage management.

Keywords

Postpartum hemorrhage Fibrinogen Blood coagulation tests Hemostasis 

References

  1. 1.
    Szecsi PB, Jørgensen M, Klajnbard A, et al. Haemostatic reference intervals in pregnancy. Thromb Haemost. 2010;103:718–27.CrossRefPubMedGoogle Scholar
  2. 2.
    Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;5:266–73.CrossRefPubMedGoogle Scholar
  3. 3.
    de Lloyd L, Bovington R, Kaye A, et al. Standard haemostatic tests following major obstetric hemorrhage. Int J Obstet Anesth. 2011;20:135–41.CrossRefPubMedGoogle Scholar
  4. 4.
    Green L, Knight M, Seeney F, et al. The haematological features and transfusion management of women who required massive transfusion for major obstetric haemorrhage in the UK: a population based study. Br J Haematol. 2016;172:616–24.CrossRefPubMedGoogle Scholar
  5. 5.
    Huissoud C, Carrabin N, Benchaib M, et al. Coagulation assessment by rotation thromboelastometry in normal pregnancy. Thromb Haemost. 2009;101:755–61.PubMedGoogle Scholar
  6. 6.
    Polak F, Kolnikova I, Lips M, et al. New recommendations for thromboelastography reference ranges for pregnant women. Thromb Res. 2011;128:e14–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Collins PW, Lilley G, Bruynseels D, et al. Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study. Blood. 2014;124:1727–36.CrossRefPubMedGoogle Scholar
  8. 8.
    Abdul-Kadir R, McLintock C, Ducloy AS, et al. Evaluation and management of postpartum hemorrhage: consensus from an international expert panel. Transfusion. 2014;54:1756–68.CrossRefPubMedGoogle Scholar
  9. 9.
    Lyndon A, Lagrew D, Shields LM, et al. Improving health care response to obstetric hemorrhage. California Maternal Quality Care Collaborative. https://cmqcc.org/ob_hemorrhage. Last accessed 7 June 2017.
  10. 10.
    Society for the Advancement of Blood Management. Administrative and clinical standards for patient blood management programs, 3rd ed. 2014. http://www.sabm.org/publications. Last accessed 7 June 2017.
  11. 11.
    Chandler WL, Ferrell C, Trimble S, Moody S. Development of a rapid emergency hemorrhage panel. Transfusion. 2010;50:2547–52.CrossRefPubMedGoogle Scholar
  12. 12.
    Shaylor R, Weiniger CF, Austin N, et al. National and international guidelines for patient blood management in obstetrics: a qualitative review. Anesth Analg. 2017;124:216–32.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of PathologyUniversity of New Mexico Health Science CenterAlbuquerqueUSA

Personalised recommendations